Biotech Essentials

05/04/2023

A mini-heart in a Petri dish https://buff.ly/3KwKQ2S via

A team of scientists at TUM has induced stem cells to emulate the development of the human heart. The result is a sort of “mini-heart” known as an organoid.

05/04/2023

Cure Ventures Launches with $350M to De-Risk Innovation https://buff.ly/40KM2p4 via

With an inaugural $350 million fund, Cure Ventures launched Tuesday to support early-stage companies with cutting-edge curative technologies and help them de-risk their science

05/04/2023

Sensible Biotechnologies Partners with Ginkgo to Develop Novel mRNA Manufacturing Platform https://buff.ly/40FFc3T via

mRNA technology has the potential to help develop many life-saving therapeutics and vaccines.

05/04/2023

The ‘new, old kids’ on the biotech block unveil a $350M stealth science fund. And they’re going very, very early https://buff.ly/3KyK7xW via

Richard Lim and his two co-founders at Cure Ventures have some biotech stories to tell. Lim recalls the time some 17 years ago he and Lou Tartaglia were going to start something — but then Tartaglia jumped to Third Rock as Kevin Starr and Bob Tepper were ramping things up,

05/04/2023

Biden-Harris Administration Announces $6.5 Billion for Drinking Water Infrastructure Upgrades Across the Country https://buff.ly/40Hps0t via

EPA News Release: Biden-Harris Administration Announces $6.5 Billion for Drinking Water Infrastructure Upgrades Across the Country

05/04/2023

Why the European Union needs to grow genetically-engineered crops https://buff.ly/3nLCkUJ via

The United States, Argentina, Brazil, Canada, Israel, Japan, and India are among the growing number of countries that have deregulated or have decided not to regulate CRISPR gene-edited plants and other new plant breeding techniques (NPBTs).

05/04/2023

What to know about the National Cancer Plan https://buff.ly/40It1Ua via

We have details on Biden’s National Cancer Plan—and why price controls may stop innovation in its tracks. Plus, everyone’s talking about AI, so we look at how biotech’s using it to make tasty protein alternatives. (499 words, 2 minutes, 29 seconds)

05/04/2023

Cure Ventures Debuts With $350 Million Biotech Fund https://buff.ly/437HE4L via

Three entrepreneurs experienced in building and funding biotechnology companies and who launched Cure Ventures have raised $350 million for the firm’s first life-sciences fund.

05/04/2023

Biogen Appoints Adam Keeney as Head of Corporate Development https://buff.ly/40JvbTn via

CAMBRIDGE, Mass., April 04, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Adam Keeney, Ph.D., as Executive Vice...

05/04/2023

From a public library whiteboard, a $350 million biotech venture fund https://buff.ly/40F1xi4 via

A new biotech VC firm started by veterans of the industry began with talks around a whiteboard in public libraries in Newton and Wellesley, Mass.

05/04/2023

iNtRON looks to control colorectal cancer through microbiome https://buff.ly/3nMGuM4 via

iNtRON Biotechnology has announced that it has demonstrated the effectiveness of bacteriophage-based drugs for cancer control.

05/04/2023

Okyo Pharma abandons UK listing in favour of Nasdaq https://buff.ly/3GjUZNT via

Okyo Pharma abandons UK listing in favour of Nasdaq News Okyo Pharma has decided to delist its shares from the London Stock Exchange and list them on the Nasdaq in New York, blaming “negligible” trading that doesn’t justify the associated costs. The decision comes amid concerns that the LSE is...

05/04/2023

Sensible Biotechnologies Partners with Ginkgo to Develop Novel mRNA Manufacturing Platform https://buff.ly/412FEsR via

mRNA technology has the potential to help develop many life-saving therapeutics and vaccines.

05/04/2023

From a public library whiteboard, a $350 million biotech venture fund https://buff.ly/3U7XPv5 via

A new biotech VC firm started by veterans of the industry began with talks around a whiteboard in public libraries in Newton and Wellesley, Mass.

05/04/2023

Genome Sequence and Analysis of Nicotiana benthamiana, the Model Plant for Interactions between Organisms https://buff.ly/413PURQ via

Abstract. Nicotiana benthamiana is widely used as a model plant for dicotyledonous angiosperms. In fact, the strains used in research are highly susceptible to

05/04/2023

Orphan Crops for Food Security and Agricultural Sustainability in the 21st Century: Reclaiming Their Lost Glory https://buff.ly/3U8ZxMw via

This article collection will focus on the recent advances that have improved the understanding of the biology and breeding of orphan crops.

05/04/2023

Solvay announces strategic collaboration with Ginkgo Bioworks and expands its R&I footprint in the United States https://buff.ly/3GkjlHb via

The investment will accelerate the development of new sustainable biopolymers, strengthening Solvay’s position in biotechnology in this important growth platform.

05/04/2023

England Allows Gene-Edited Crops https://buff.ly/3zErVwx via

This has been somewhat of a quiet revolution, but a new law in England may bring it to the foreground. The Precision Breeding Act will now allow gene-edited plants to be developed and marketed in England (not Northern Ireland, Wales, or Scotland). The innovation is that the law makes a distinction b

05/04/2023

BIO-Europe Spring 2023: The Highlights https://buff.ly/40XZvt7 via

As BIO Europe Spring took place from March 20 to 22, here are some of the key take-home reports from the event.

04/04/2023

Sensible Biotechnologies And Ginkgo Bioworks Announce Partnership To Make In Vivo RNA To Unlock The Promise Of RNA Therapeutics https://buff.ly/3nDTiEl via

Coaxing cells to produce mRNA for therapeutic applications has been an unsuccessful endeavor so far. Miroslav Gasparek is on a mission to use synbio to change that. His company Sensible Biotechnologies is partnering with Ginkgo Bioworks to develop the next generation of mRNA therapeutics.

04/04/2023

GC Cell and New Management Embarking on a New Chapter https://buff.ly/412IMFj via

GC Cell, a Korean biotech company, announced on Mar. 28th that it had held the 12th General Shareholders' Meeting at GC Biopharma R&D Center in Yongin, Gyeonggi-do of South Korea and resolved some major agenda items, including the appointment of inside directors.

04/04/2023

Empowering Women in Biotech https://buff.ly/3Gjesy3 via

Taking place on 18th April between 9.30am – 3.30pm, this event aims to bring together likeminded individuals working in the biotech and life science sector, and women looking to pursue a career in this industry. We will have talks from inspirational women in the industry on topics ranging from le...

04/04/2023

Buildings Crumble High in the Alps as Permafrost Thaws https://buff.ly/40WCJSn via

Safe access to the world’s tallest peaks could disappear as temperatures rise in the Alps

04/04/2023

The biggest private biotech investments in March 2023 https://buff.ly/435QgJ8 via

The companies Wilson Wolf Corporation, Cargo Therapeutics and Noema Pharma bagged the biggest biotech investments in March 2023.

04/04/2023

In Brazil, scientists fight an uphill battle to restore the disappearing Cerrado savanna https://buff.ly/3ZFdDX2 via

Brasília National Forest is a Paris-sized oasis of green surrounded on three sides by concrete satellite cities that serve Brazil’s capital city. Extensive trails and expanses of forest make it popular among mountain bikers and joggers who can be seen running beneath the shade of pine and eucalyp...

04/04/2023

BioNTech moves into ADCs with Duality deal https://buff.ly/3KxexR6 via

The biotech is expanding its cancer medicine pipeline by licensing two experimental antibody drug conjugates from Shanghai-based Duality.

04/04/2023

StockWatch: COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron https://buff.ly/3KxZwih via

Regeneron Pharmaceuticals shares rose 10% following positive Phase III data for Dupixent® in chronic obstructive pulmonary disease (COPD).

04/04/2023

Welcome to PowerPoint https://buff.ly/412WfwN via

04/04/2023

GC Cell and New Management Embarking on a New Chapter https://buff.ly/43gDacv via

GC Cell, a Korean biotech company, announced on Mar. 28th that it had held the 12th General Shareholders' Meeting at GC Biopharma R&D Center in Yongin, Gyeonggi-do of South Korea and resolved some major agenda items, including the appointment of inside directors.

04/04/2023

Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update https://buff.ly/3MeZLjj via

Kineta, Inc. announced financial results for the full-year ended December 31, 2022 and provided a corporate update.